PolyPid (PYPD) News Today $3.49 -0.11 (-3.06%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period PolyPid (PYPD) Gets a Hold from BarclaysNovember 19 at 5:45 AM | markets.businessinsider.comPositive Indicators and Financial Stability Support Roy Buchanan’s Optimistic Outlook on PolyPid’s StockNovember 16, 2024 | markets.businessinsider.comPolyPid Reports Q3 Results Amid SHIELD II Trial ProgressNovember 15, 2024 | markets.businessinsider.comPolyPid Announces SHIELD II Trial Progress and FinancialsNovember 14, 2024 | markets.businessinsider.comPolyPid Ltd. (PYPD) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comPolyPid (PYPD) Receives a Buy from Craig-HallumNovember 12, 2024 | markets.businessinsider.comPolyPid Announces $8.25 Million Share Sale PlanNovember 9, 2024 | markets.businessinsider.comPolyPid to Participate in the Craig-Hallum 15th Annual Alpha Select ConferenceNovember 7, 2024 | globenewswire.comCraig-Hallum bullish on PolyPid, initiates with a BuyNovember 6, 2024 | markets.businessinsider.comCraig-Hallum Initiates Coverage of PolyPid (PYPD) with Buy RecommendationNovember 6, 2024 | msn.comPolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024October 30, 2024 | globenewswire.comRosalind Advisors, Inc. Reduces Stake in PolyPid LtdOctober 24, 2024 | finance.yahoo.comPolyPid announces publication in IJS on Phase 3 SHIELD I trial of D-PLEX100October 22, 2024 | markets.businessinsider.comPolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal SurgeryOctober 21, 2024 | globenewswire.comPolyPid retains stock target, buy rating on positive trial enrollment updateOctober 4, 2024 | investing.comPolyPid completes enrollment for phase 3 trialOctober 3, 2024 | uk.investing.comBuy Rating Affirmed for PolyPid on D-PLEX’s Positive Trial Milestones and Commercial ProspectsOctober 3, 2024 | markets.businessinsider.comPolyPid Buy Rating Affirmed: Promising Clinical Trials and Solid Financial OutlookOctober 2, 2024 | markets.businessinsider.comPolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site InfectionsOctober 1, 2024 | globenewswire.comPolyPid to Participate in Three Upcoming Fall Investor ConferencesSeptember 3, 2024 | globenewswire.comPolyPid (PYPD) Receives a Hold from BarclaysAugust 20, 2024 | markets.businessinsider.comPolyPid Ltd (PYPD) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | seekingalpha.comBuy Rating Affirmed for PolyPid Amidst Strong Trial Progress and Robust Financial PositionAugust 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for PolyPid on D-PLEX Clinical Progress and Potential Early ApprovalAugust 16, 2024 | markets.businessinsider.comPolyPid Ltd. (NASDAQ:PYPD) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | insidermonkey.comPolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsAugust 14, 2024 | finance.yahoo.comPolyPid secures $14 million in private placementAugust 4, 2024 | investing.comPolyPid Announces Private Placement for Up to $14 Million in Gross ProceedsAugust 1, 2024 | globenewswire.comPolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024July 31, 2024 | globenewswire.comPolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company's Ongoing D-PLEX₁₀₀ Phase 3 TrialJune 10, 2024 | globenewswire.comEarnings call: PolyPid reports progress in D-PLEX100 trial, eyes expansionMay 12, 2024 | investing.comPolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comBuy Rating Affirmed for PolyPid on D-PLEX Progress and Solid Financial FootingMay 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Cartesian Therapeutics (RNAC)May 8, 2024 | markets.businessinsider.comPYPD Stock Earnings: PolyPid Beats EPS for Q1 2024May 8, 2024 | investorplace.comPolyPid Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 8, 2024 | globenewswire.comPolyPid to Participate in Citizens JMP Life Sciences ConferenceMay 1, 2024 | globenewswire.comBuy Rating Affirmed for PolyPid on Strong Trial Progress and Expanding Pipeline PotentialApril 30, 2024 | markets.businessinsider.comPolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site InfectionsApril 30, 2024 | globenewswire.comPYPD: Polypid is Enhancing Surgical OutcomesApril 24, 2024 | msn.comPolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024April 24, 2024 | globenewswire.comPolyPid Ltd. (PYPD) Stock Historical Prices & Data - Yahoo FinanceApril 18, 2024 | finance.yahoo.comPolyPid to Participate in Barclays 26th Annual Global Healthcare ConferenceFebruary 28, 2024 | globenewswire.comPolyPid Ltd. (PYPD) Upgraded to Buy: What Does It Mean for the Stock?February 19, 2024 | finance.yahoo.comPolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call TranscriptFebruary 15, 2024 | finance.yahoo.comBuy Rating for PolyPid Amid Positive D-PLEX100 Trial Prospects and Strategic Market PositioningFebruary 14, 2024 | markets.businessinsider.comPolyPid Ltd.: PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 14, 2024 | finanznachrichten.dePolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 14, 2024 | finance.yahoo.comPolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 14, 2024 | globenewswire.comPolyPid Ltd.: PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 TrialFebruary 12, 2024 | finanznachrichten.de Get PolyPid News Delivered to You Automatically Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. PYPD Media Mentions By Week PYPD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PYPD News Sentiment▼1.080.45▲Average Medical News Sentiment PYPD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PYPD Articles This Week▼51▲PYPD Articles Average Week Get PolyPid News Delivered to You Automatically Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Hyperfine News electroCore News Lucid Diagnostics News Alpha Pro Tech News Nutriband News Apyx Medical News Cytosorbents News Nexalin Technology News CollPlant Biotechnologies News Milestone Scientific News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PYPD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolyPid Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PolyPid With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PYPD Stock Alerts